Drug Benefits and Risks: International Textbook of Clinical PharmacologyChris J. van Boxtel, Budiono Santoso, I. Ralph Edwards Wiley, 28 nov. 2001 - 734 pagini This is an inclusive reference exploring the scientific basis and practice of drug therapy. The key concept is to look at the balance between the benefits and risks of drugs but in this context also the social impact which drugs have in modern societies is highlighted. Taking an evidence-based approach to the problem, the practice of clinical pharmacology and pharmacotherapy in the developing as well as the developed world is examined. For this purpose the book * Covers general clinical pharmacology, pharmacology of various drug groups and the treatments specific to various diseases * Gives guidance on how doctors should act so that drugs can be used effectively and safely * Encourages the rational use of drugs in society This book brings together a large amount of excellent content that will be invaluable for anyone working within, or associated with, the field of clinical pharmacology and pharmacotherapy - undergraduates, postgraduates, regulatory authorities and the pharmaceutical industry. |
Cuprins
Contents | 4 |
Modern Medicine | 159 |
Department of Internal Medicine Nippon Faculty University of Indonesia 6 Salemba | 221 |
Drept de autor | |
13 alte secțiuni nu sunt arătate
Alte ediții - Afișează-le pe toate
Drug Benefits and Risks: International Textbook of Clinical Pharmacology Chris J. van Boxtel,Budiono Santoso,I. Ralph Edwards Previzualizare limitată - 2001 |
Termeni și expresii frecvente
absorption acid action activity acute administration adverse adverse effects agents antagonists antibiotics associated benefit binding blood body cancer cause cells changes chronic clinical Cochrane combination common compounds concentration considered costs countries decrease dependent disease disorders dose drug effects efficacy elimination enzyme et al evidence example factors failure frequently function given glucose half-life heart hypertension important improve increase indicated induce infections inhibition inhibitors insulin interactions intravenous lead less levels liver major measures mechanism medicines ment metabolism myocardial infarction normal occur oral organ pain patients Pharmacology Phase plasma possible potential practice pressure prevent problems protein reactions receptors reduced renal reported resistance response result risk selective severe side specific studies symptoms Table therapeutic therapy tion tissue toxicity treat treatment trials usually vitamin